Results 1 to 10 of about 100,300 (318)

Drug eluting stents [PDF]

BMJ, 2006
Last week an expert panel of the US Food and Drug Administration (FDA) recommended that the FDA should issue warnings to doctors and patients about drug eluting coronary stents. The safety of such stents is unclear except in low risk patients. Furthermore, patients with drug eluting stents should take antiplatelet therapy for at least one year after ...
Gershlick, AH, Richardson, G
  +9 more sources

Drug-eluting stents [PDF]

Canadian Medical Association Journal, 2007
In their recent systematic review, Suzanne Ligthart and associates compared analyses of the cost-effectiveness of drug-eluting stents.[1][1] They found that in most studies in which an incremental cost-effectiveness ratio greater than $50 000 per quality-adjusted life-year was calculated the ...
E Liana, Falcone, Navdeep, Tangri
openaire   +4 more sources

Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern

CVIR Endovascular, 2021
Background Although several clinical reports demonstrated a durable patency rate after a novel fluoropolymer-coated paclitaxel-eluting stent (Eluvia; Boston Scientific, Marlborough, MA, USA) placement, aneurysmal degeneration after drug-eluting stent ...
Takuya Tsujimura, Osamu Iida, Mitsutoshi Asai, Masaharu Masuda, Shin Okamoto, Takayuki Ishihara, Kiyonori Nanto, Takashi Kanda, Yasuhiro Matsuda, Yosuke Hata, Hiroyuki Uematsu, Taku Toyoshima, Naoko Higashino, Toshiaki Mano   +13 more
doaj   +1 more source

Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Percutaneous coronary intervention of calcified lesions was associated with worse outcomes in the era of bare‐metal and first‐generation drug‐eluting stents. Data on percutaneous coronary intervention of calcified lesions with newer‐generation
Rayyan Hemetsberger, Mohammad Abdelghani, Ralph Toelg, Nader Mankerious, Abdelhakim Allali, Hector M. Garcia‐Garcia, Stephan Windecker, Thierry Lefèvre, Shigeru Saito, Ton Slagboom, David Kandzari, Jacques Koolen, Ron Waksman, Gert Richardt   +13 more
doaj   +1 more source

Stent thrombosis and drug-eluting stents [PDF]

Journal of Cardiology, 2011
Coronary stents have been used for the treatment of patients with coronary artery disease (CAD), and significantly improved procedural safety and are associated with a lower rate of restenosis compared with balloon angioplasty alone. Drug-eluting stents (DES) have been dominant for the treatment of CAD with efficacy in significantly reducing both ...
Takayama, Tadateru, Hiro, Takafumi, Hirayama, Atsushi   +2 more
openaire   +2 more sources

Progress in treatment by percutaneous coronary intervention: The stent of the future [PDF]

, 2013
First generation drug-eluting stents have considerably reduced in-stent restenosis and broadened the applications of percutaneous coronary interventions for the treatment of coronary artery disease.
Bourantas, C.V. (Christos), Diletti, R. (Roberto), Farooq, V. (Vasim), Garcia-Garcia, H.M. (Hector), Garg, S.A. (Scot), Gogas, B.D. (Bill), Kharlamov, A.N. (Alexander ), Muramatsu, T. (Takashi), Onuma, Y. (Yoshinobu), Ozaki, Y. (Yukio), Serruys, P.W.J.C. (Patrick), Zhang, Y. (Yaojun)   +11 more
core   +3 more sources

Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention: The Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV) [PDF]

, 2012
BACKGROUND: Among drug-eluting stents released to date, the sirolimus-eluting stent has demonstrated the least amount of late lumen loss, but its efficacy and safety have not been compared head-to-head with the next-generation everolimus-eluting stent ...
Aarøe, Jens, Boel Villadsen, Anton, Bøtker, Hans Erik, Christiansen, Evald Høj, Hansen, Hans-Henrik Tilsted, Hansen, Henrik Steen, Junker, Anders, Kaltoft, Anne, Kristensen, Steen Dalby, Krusell, Lars Romer, Lassen, Jens Flensted, Madsen, Morten, Maeng, Michael, Nørregaard Hansen, Knud, Okkels Jensen, Lisette, Pedersen, Knud Erik, Ravkilde, Jan, Sanchez, Richardo, Sørensen, Henrik Toft, Thayssen, Per, Thuesen, Leif   +20 more
core   +1 more source

A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]

, 2016
Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L., Kennedy, Simon, McCormick, Christopher, Mullen, Alexander B., Wadsworth, Roger M.   +4 more
core   +2 more sources

An Analysis of Cost-Effectiveness of Stents Used in the Treatment of Coronary Artery Disease

Balkan Medical Journal, 2019
Background: There is only limited information about the cost-effectiveness of drug-eluting stents compared with bare-metal stents in Turkey. Aims: To evaluate bare-metal and drug-eluting stents used in the treatment of coronary artery disease from the ...
Ferda Işıkçelik, İsmail Ağırbaş, Cansın Tulunay Kaya   +2 more
doaj   +1 more source

Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature [PDF]

, 2012
Background: A novel self-expanding drug-eluting stent was designed to release everolimus 225 mu g/cm(2) to prevent restenosis following peripheral arterial intervention.
Hausegger, Klaus A, Koppensteiner, Renate, Lammer, Johannes, Mellon, Rajeev M, Scheinert, Dierk, Schroë, Herman, Schwartz, Lewis B, Vermassen, Frank   +7 more
core   +2 more sources